Our journey began in 2013 with the development of a cutting-edge synthetic bone graft material, Ceragraft®. After several studies being published demonstrating its enormous potential, Ossmed® was founded in late 2017 with the aim of combining the expertise coming from different complementary areas of science (engineering, biology and medicine) to develop new generations of evidence-based implantable medical devices for bone and tissue regeneration.
At Ossmed® we believe that every patient should be able to benefit from cutting-edge medical technologies for bone and tissue regeneration. From scientific breakthrough, biological testing, to product development and manufacturing, we create innovative solutions that improve the future of healthcare. Our passionate R&D team focuses on the development of an ever-increasing range of high-quality solutions, crafted to meet the singular requirements of each patient and medical indication. For Ossmed®, providing a high level of medical care, with innovative and patient-tailored solutions, is a long-term commitment that enables professionals to improve their patients’ health and quality of life.